V. Institut-de and . Sanitaire, Bulletin épidémiologique hebdomadaire, Alcool et santé en France, état des lieux, 12 septembre, 2006.

M. Reynaud, J. Ades, and P. Angel, Traité d'addictologie, Flammarion Médecine-Sciences, 2006.

L. France, un coût dénié, 1ères rencontres parlementaires sur le problème de l'alcool, 2010.

D. Mennecier and M. Thomas, Traitement de l'alcoolod??pendance, EMC - Gastro-ent??rologie, vol.4, issue.3, pp.1-11, 2009.
DOI : 10.1016/S1155-1968(09)46459-9

C. Mombereau, K. Kaupmann, and W. Froestl, Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like Behavior, Neuropsychopharmacology, vol.29, issue.6, pp.1050-1062, 2004.
DOI : 10.1038/sj.npp.1300413

C. Mombereau, Géosciences et Sciences de l'environnement, « Etude du rôle des récepteurs GABAB dans l'anxiété, la dépression et l'addiction : Approche pharmacologique et génétique, Thèse de Doctorat en Sciences du vivant, 2006.

M. Breslow, M. Fankhauser, and R. Potter, Role of gammaaminobutyric acid in antipanic drug efficacy, Am J Psychiatry, vol.146, pp.353-356, 1989.

R. Drake, L. Davis, and M. Cates, Baclofen Treatment for Chronic Posttraumatic Stress Disorder, Annals of Pharmacotherapy, vol.61, issue.9, pp.1177-1181, 2003.
DOI : 10.1097/00004850-199903000-00001

D. Slattery, S. Desrayaud, and J. Cryan, GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent, Journal of Pharmacology and Experimental Therapeutics, vol.312, issue.1, pp.290-296, 2005.
DOI : 10.1124/jpet.104.073536

J. Cryan and D. Slattery, GABAB Receptors and Depression: Current Status, Adv Pharmacol, vol.58, pp.427-451, 2010.
DOI : 10.1016/S1054-3589(10)58016-5

M. Frankowska, M. Filip, and E. Przegalinski, Effects of GABAB receptor ligands in animal tests of depression and anxiety, Pharmacol Rep, vol.59, issue.6, pp.645-655, 2007.

J. Vienne, B. Bettler, and P. Franken, Differential effects of GABA B receptor subtypes, J-hydroxybutyric acid, and baclofen on EEG activity and sleep regulation, The Journal of Neuroscience, vol.30, issue.42, pp.14174-14204, 2010.

M. Cousins, D. Roberts, and H. De-wit, GABAB receptor agonists for the treatment of drug addiction: a review of recent findings, Drug and Alcohol Dependence, vol.65, issue.3, pp.209-220, 2002.
DOI : 10.1016/S0376-8716(01)00163-6

S. Française-d-'alcoologie, Neurobiologie-Effets cellulaires et moléculaires de l'éthanol, 2011.

M. Soyka, H. Kranzler, and M. Berglund, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism, The World Journal of Biological Psychiatry, vol.25, issue.11, pp.6-23, 2008.
DOI : 10.1093/schbul/23.2.215

M. Lejoyeux, Conduites alcooliques??: pr??vention et traitement, EMC - Psychiatrie, vol.6, issue.4, pp.1-11, 2009.
DOI : 10.1016/S0246-1072(09)48891-6

E. Setiawan, R. O. Pihl, and S. M. Cox, The Effect of Naltrexone on Alcohol???s Stimulant Properties and Self-Administration Behavior in Social Drinkers: Influence of Gender and Genotype, Alcoholism: Clinical and Experimental Research, vol.146, issue.6, pp.1134-1141, 2011.
DOI : 10.1111/j.1530-0277.2011.01446.x

S. Pirot, Les nouvelles directions thérapeutiques dans l'alcoolisme : le récepteur NK1 à l'honneur. Neuropsychiatrie : tendances et débats, pp.45-50, 2009.

F. Caputo, T. Vignoli, and I. Maremmani, Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review, International Journal of Environmental Research and Public Health, vol.6, issue.6, pp.1917-1929, 2009.
DOI : 10.3390/ijerph6061917

S. Karhuvaara, K. Simojoki, and A. Virta, Targeted Nalmefene With Simple Medical Management in the Treatment of Heavy Drinkers: A Randomized Double-Blind Placebo-Controlled Multicenter Study, Alcoholism: Clinical and Experimental Research, vol.22, issue.7, pp.1179-1187, 2007.
DOI : 10.1093/alcalc/35.2.202

O. Ameisen and R. De-beaurepaire, Suppression de la d??pendance ?? l???alcool et de la consommation d???alcool par le baclof??ne ?? haute dose??: un essai en ouvert, Annales M??dico-psychologiques, revue psychiatrique, vol.168, issue.2, pp.159-162, 2010.
DOI : 10.1016/j.amp.2009.12.008

C. Smith, N. Larocca, and B. Giesser, High-dose oral baclofen: Experience in patients with multiple sclerosis, Neurology, vol.41, issue.11, pp.1829-1831, 1991.
DOI : 10.1212/WNL.41.11.1829

N. Leung, I. Whyte, and G. Isbister, Baclofen overdose: Defining the spectrum of toxicity, Emergency Medicine Australasia, vol.35, issue.1, pp.77-82, 2006.
DOI : 10.1016/S0196-0644(03)00600-0

J. Nay, Suppression of alcoholism with baclofen: a physician's personal story. Revue Médicale Suisse. 15 octobre, p.2234, 2008.

O. Ameisen, COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN, Alcohol and Alcoholism, vol.40, issue.2, pp.147-50, 2005.
DOI : 10.1093/alcalc/agh130

W. Bucknam, SUPPRESSION OF SYMPTOMS OF ALCOHOL DEPENDENCE AND CRAVING USING HIGH-DOSE BACLOFEN, Alcohol and Alcoholism, vol.42, issue.2, pp.158-60, 2007.
DOI : 10.1093/alcalc/agl091

V. «. Boy-landry, Baclofène la molécule qui guérit l'alcoolisme ? ». Paris Match, Mars, vol.2011, pp.37-40

D. «. Pierrat, Contre l'alcoolisme qu'attend-on pour autoriser le baclofène ». Top Santé, Novembre, vol.2010, pp.14-16

S. Française-d-'alcoologie, Communiqué du 30 novembre 2010, 2011.

R. Article, 4127-8 du Code de la Santé Publique : liberté de prescription

B. Rolland, S. Deheul, and T. Danel, Un dispositif de prescriptions hors-AMM : exemple du baclof??ne, Th??rapie, vol.65, issue.6, pp.511-518, 2010.
DOI : 10.2515/therapie/2010073

J. Tarika and G. Winger, The effects of ethanol, phenobarbital, and baclofen on ethanol withdrawal in the rhesus monkey, Psychopharmacology, vol.215, issue.8, pp.201-208, 1980.
DOI : 10.1007/BF00435315

R. Humeniuk, J. White, and J. Onq, The effects of GABAB ligands on alcohol withdrawal in mice, Pharmacology Biochemistry and Behavior, vol.49, issue.3, pp.561-566, 1994.
DOI : 10.1016/0091-3057(94)90069-8

S. File, A. Zharkovski, and K. Gulati, Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat, Neuropharmacology, vol.30, issue.2, pp.183-190, 1991.
DOI : 10.1016/0028-3908(91)90202-M

S. File, A. Zharkovsky, and P. Hitchcott, Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.16, issue.1, pp.87-93, 1992.
DOI : 10.1016/0278-5846(92)90011-3

G. Colombo, R. Agabio, and M. Carai, Ability of Baclofen in Reducing Alcohol Intake and Withdrawal Severity: I-Preclinical Evidence, Alcoholism: Clinical and Experimental Research, vol.290, issue.1, pp.58-66, 2000.
DOI : 10.1016/0014-2999(92)90347-7

D. Knapp, D. Overstreet, and G. Breese, Baclofen Blocks Expression and Sensitization of Anxiety-Like Behavior in an Animal Model of Repeated Stress and Ethanol Withdrawal, Alcoholism: Clinical and Experimental Research, vol.290, issue.2, pp.582-595, 2007.
DOI : 10.1016/S0028-3908(99)00126-4

G. Colombo, S. Serra, and G. Vacca, Baclofen-induced suppression of alcohol deprivation effect in sP rats exposed to different alcohol concentrations

G. Colombo, G. Vacca, and S. Serra, Baclofen suppresses motivation to consume alcohol in rats, Psychopharmacology, vol.22, issue.3, pp.221-224, 2003.
DOI : 10.1016/S0741-8329(01)00157-4

B. Walker and G. Koob, The ?-Aminobutyric Acid-B Receptor Agonist Baclofen Attenuates Responding for Ethanol in Ethanol-Dependent Rats, Alcoholism: Clinical and Experimental Research, vol.290, issue.1, pp.11-18, 2007.
DOI : 10.1016/j.pbb.2004.05.006

M. Stromberg, The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat, Pharmacology Biochemistry and Behavior, vol.78, issue.4, pp.743-750, 2004.
DOI : 10.1016/j.pbb.2004.05.006

J. Liang, F. Chen, and E. Krstew, The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats, Neuropharmacology, vol.50, issue.5, pp.632-639, 2006.
DOI : 10.1016/j.neuropharm.2005.11.011

G. Addolorato, L. Leggio, and R. Agabio, Baclofen: a new drug for the treatment of alcohol dependence, International Journal of Clinical Practice, vol.40, issue.8, pp.1003-1008, 2006.
DOI : 10.1111/j.1742-1241.2006.01065.x

G. Addolorato, L. Leggio, and L. Abenavoli, Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam, The American Journal of Medicine, vol.119, issue.3, pp.276-289, 2006.
DOI : 10.1016/j.amjmed.2005.08.042

W. Stallings and S. Schrader, Baclofen as prophylaxis and treatment for alcohol withdrawal: a retrospective chart review, J Okla State Med Assoc, vol.100, pp.354-60, 2007.

G. Addolorato, L. Leggio, and L. Abenavoli, Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report, Clinical Neuropharmacology, vol.26, issue.5, pp.258-262, 2003.
DOI : 10.1097/00002826-200309000-00010

P. Gache and A. Hadengue, Baclofen improves abstinence in alcoholic cirrhosis: Still better to come?, Journal of Hepatology, vol.49, issue.6, pp.1083-1085, 2008.
DOI : 10.1016/j.jhep.2008.09.008

G. Addolorato, F. Caputo, and E. Capristo, Ability of Baclofen in Reducing Alcohol Craving and Intake: II-Preliminary Clinical Evidence, Alcohol Clin Exp Res, vol.24, pp.67-71, 2000.

B. Flannery, J. Garbutt, and M. Cody, Baclofen for Alcohol Dependence: A Preliminary Open-Label Study, Alcoholism: Clinical & Experimental Research, vol.12, issue.10, pp.1517-1523, 2004.
DOI : 10.1111/j.1360-0443.1989.tb00737.x

A. Avanesyan and B. Runyon, Utilization of baclofen in maintenance of alcohol abstinence in patients with alcoholic hepatitis in a real-life clinical setting, Hepatology, vol.52, p.1641, 2010.

P. Gache, Baclofène : vérités et promesses d'un « nouveau » venu dans le traitement de l'alcoolodépendance, Alcoologie et Addictologie, vol.32, pp.119-124, 2010.

G. Addolorato, F. Caputo, and E. Capristo, BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY, Alcohol and Alcoholism, vol.37, issue.5, pp.504-508, 2002.
DOI : 10.1093/alcalc/37.5.504

G. Addolorato, L. Leggio, and A. Ferrulli, Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, The Lancet, vol.370, issue.9603, pp.1915-1922, 2007.
DOI : 10.1016/S0140-6736(07)61814-5

J. Garbutt, A. Kampov-polevoy, and R. Gallop, Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial, Alcoholism: Clinical and Experimental Research, vol.12, issue.11, pp.1849-1857, 2010.
DOI : 10.1111/j.1530-0277.2010.01273.x

G. Addolorato, L. Leggio, and A. Ferrulli, Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial, Alcohol and Alcoholism, vol.46, issue.3, pp.312-317, 2011.
DOI : 10.1093/alcalc/agr017

S. Evans, . Bisaga-phd, and A. Bisaga, Acute Interaction of Baclofen in Combination With Alcohol in Heavy Social Drinkers, Alcoholism: Clinical and Experimental Research, vol.33, issue.1, pp.19-30, 2009.
DOI : 10.1111/j.1530-0277.2008.00805.x

G. M. Dore, K. Lo, and L. Juckes, Clinical Experience with Baclofen in the Management of Alcohol-Dependent Patients with Psychiatric Comorbidity: A Selected Case Series, Alcohol and Alcoholism, vol.46, issue.6, pp.714-720, 2011.
DOI : 10.1093/alcalc/agr131

R. Agabio and M. , Baclofen Suppresses Alcohol Intake and Craving for Alcohol in a Schizophrenic Alcohol-Dependent Patient, Journal of Clinical Psychopharmacology, vol.27, issue.3, pp.319-320, 2007.
DOI : 10.1097/01.jcp.0000270079.84758.fe

A. Bouzidi, Thèse de Doctorat en Médecine, « Evaluation du Baclofène dans la prise en charge de l'alcoolodépendance (à partir d'un essai clinique ouvert), 2010.

?. Alexandre and C. Dubroeucq, Thèse de Doctorat en Médecine, « Alcool et Baclofène : étude prospective sur 132 patients suivis pendant un an en ambulatoire, 2011.

R. De-beaurepaire, Baclofen for the treatment of alcoholism, PSN, vol.158, issue.6684, pp.1-6, 2011.
DOI : 10.1007/s11836-010-0159-2

L. Leggio, J. Garbutt, and G. Addolorato, Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients, CNS & Neurological Disorders - Drug Targets, vol.9, issue.1, pp.33-44, 2010.
DOI : 10.2174/187152710790966614

O. Ameisen, Gamma-Hydroxybutyrate (GHB)-Deficiency in alcohol-dependence?, Alcohol and Alcoholism, vol.42, issue.5, p.506, 2007.
DOI : 10.1093/alcalc/agm058

G. Addolorato, L. Leggio, and S. Cardone, Role of the GABAB receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives, Alcohol, vol.43, issue.7, pp.559-563, 2009.
DOI : 10.1016/j.alcohol.2009.09.031

P. Michaud, Mesurer l'appétence avec l'échelle ETIAM en recherche et en clinique quotidienne. Le courrier des addictions, pp.80-84, 2004.

H. Echelle-de-dépression, HAD : Hospital Anxiety and Depression Scale) de Sigmond et Snaith, 2011.

B. Echelle-de, BDI : Beck Depression Inventory), 2011.

C. Régional-d, Education pour la Santé Outil : Profil de santé de Duke, 2011.

H. Universitaire-de-genève, Problème d'alcool. Premier-recours.hugge .ch/_library/strategies_recommandations/problem_d_alcool_2010df.pdf

. Combine, Penn Alcohol Craving Scale. www.cscc.unc, 2011.

. Consignes, Au cours de la semaine dernière, en incluant aujourd'hui, avez-vous ressenti les choses suivantes ?